Cellectar biosciences reports complete response in a relapsed/refractory cns lymphoma patient

Response achieved in primary central nervous system lymphoma for which there is no approved treatment response achieved in primary central nervous system lymphoma for which there is no approved treatment
CLRB Ratings Summary
CLRB Quant Ranking